cariprazine (Compound)

Synonyms:Cariprazine, 839712-12-8, RGH-188, RGH 188, 3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea, MP-214, Cariprazine (RGH-188), F6RJL8B278, CHEMBL3085826, GED-129, Fri-7000188, Cariprazine(RGH188), 3,3-dimethyl-1-[(1r,4r)-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl]urea, 3-[4-[2-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethyl-urea, Cariprazine [INN], Cariprazine [USAN:INN], UNII-F6RJL8B278, Reagila, cis-Cariprazine, trans-Cariprazine, MP 214, CARIPRAZINE [MI], RGH-188; Cariprazine, Cariprazine (USAN/INN), CARIPRAZINE [USAN], CARIPRAZINE [WHO-DD], SCHEMBL184342, SCHEMBL184343, GTPL7671, SCHEMBL7861573, CHEMBL2028019, SCHEMBL22946354, CHEBI:90933, HSDB 8310, DTXSID80232867, BDBM263449, GLXC-90442, BCP14691, RGH-188;MP-214, BDBM50382290, BDBM50443094, BDBM50443101, CS-1569, DB06016, EX-A1644-1, SB16839, 3-(trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea, N'-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethylurea, NCGC00379014-01, NCGC00379014-02, NCGC00379014-03, AC-35342, AS-74411, HY-14763, US9550741, RGH-188, FT-0664381, C76682, D09997, EN300-7406880, A857938, Q2938837, RGH-188; RGH188; RGH 188; MP-214; MP 214; MP214, 3-((1r,4r)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea, 3-(cis-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)-cyclohexyl)-1,1-dimethylurea, 3-(trans-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)-cyclohexyl)-1,1-dimethylurea, N'-(trans-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl)-N,N-dimethylurea, trans-N-[4-[2-[4-(2,3-di-chlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea, 7RU, Trans-1-{4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-3,3-dimethyl-urea, trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N',N'-dimethylurea hydrochloride, Urea, N'-(trans-4-(2-(4-(2,3-dichlorophenyl)-1-piperazinyl)ethyl)cyclohexyl)-N,N-dimethyl-, Urea, N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N -diMethyl-

Pubchem:PUBCHEM:11154555

Id:262a7f4d-8e62-576a-9d4b-5eb12bd367a3

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View cariprazine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for cariprazine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with cariprazine.

Results found

Linked to

	Label	Description
	BRD-K57764956-001-02-8 Substance (Entity type)	A Substance
	DCSTRUCT ID 05037 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05037; PubChem_CID:11154555, FILE=drugcentral_drug_05037.json)
	cariprazine (8cbb33aa-e21b-484c-b35d-7df6929f2027) Collection (Entity type)	Metadatata for cariprazine
	cariprazine negatively regulates GDF15 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cariprazine negatively regulates AQP3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cariprazine negatively regulates DLK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cariprazine positively regulates SCD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cariprazine positively regulates ST6GALNAC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	narlaprevir in similarity relationship with cariprazine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	cariprazine negatively regulates SPP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS